Otsuka America Pharmaceutical, Inc.

Electronics Device Database

Devices

Device Name Model Type Certification Date
Wearable Sensor for Ambulatory Recording 02684 FCC ID 2023-02-23
Proteus Two-part patch, Model RW2 01913 FCC ID 2016-09-08

brands included: Otsuka-america-pharmaceutical, Otsuka America Pharmaceutical.


Trademarks for Otsuka America Pharmaceutical, Inc. obtained from uspto.report
Mark Image Details
AASC
"AASC"
98093493
AASC
Otsuka America Pharmaceutical, Inc.
2023-07-20
"Symbol/Image"
97412713
Symbol/Image
Otsuka America Pharmaceutical, Inc.
2022-05-16
NEPHCHEF
"NEPHCHEF"
97384072
NEPHCHEF
Otsuka America Pharmaceutical, Inc.
2022-04-27
NEPHU
"NEPHU"
97383990
NEPHU
Otsuka America Pharmaceutical, Inc.
2022-04-27
IDENTIC PHARMACEUTICAL
"IDENTIC PHARMACEUTICAL"
97384190
IDENTIC PHARMACEUTICAL
Otsuka America Pharmaceutical, Inc.
2022-04-27
NEPHU
"NEPHU"
97383942
NEPHU
Otsuka America Pharmaceutical, Inc.
2022-04-27
IMPROVING AWARENESS & PATIENT OUTCOMES
"IMPROVING AWARENESS & PATIENT OUTCOMES"
97384136
IMPROVING AWARENESS & PATIENT OUTCOMES
Otsuka America Pharmaceutical, Inc.
2022-04-27
PSYCHU
"PSYCHU"
97341124
PSYCHU
Otsuka America Pharmaceutical, Inc.
2022-03-31
WE DEFY LIMITATION, SO THAT OTHERS CAN TOO
"WE DEFY LIMITATION, SO THAT OTHERS CAN TOO"
97338800
WE DEFY LIMITATION, SO THAT OTHERS CAN TOO
Otsuka America Pharmaceutical, Inc.
2022-03-30
DIGITAL MEDICINE PIONEERS
"DIGITAL MEDICINE PIONEERS"
97204149
DIGITAL MEDICINE PIONEERS
Otsuka America Pharmaceutical, Inc.
2022-01-05
PSYCHUSIM
"PSYCHUSIM"
90832806
PSYCHUSIM
Otsuka America Pharmaceutical, Inc.
2021-07-16
ADPKDSIM
"ADPKDSIM"
90828758
ADPKDSIM
Otsuka America Pharmaceutical, Inc.
2021-07-14
SOCIETY OF VALUED MINDS
"SOCIETY OF VALUED MINDS"
90644156
SOCIETY OF VALUED MINDS
Otsuka America Pharmaceutical, Inc.
2021-04-14
READYNOW
"READYNOW"
90323628
READYNOW
Otsuka America Pharmaceutical, Inc.
2020-11-17
FIRE-LINC
"FIRE-LINC"
88918023
FIRE-LINC
Otsuka America Pharmaceutical, Inc.
2020-05-15
NEXUS
"NEXUS"
88884924
NEXUS
Otsuka America Pharmaceutical, Inc.
2020-04-23
ADPKDSIM
"ADPKDSIM"
88514776
ADPKDSIM
Otsuka America Pharmaceutical, Inc.
2019-07-15
REVA
"REVA"
88412989
REVA
Otsuka America Pharmaceutical, Inc.
2019-05-02
"Symbol/Image"
88413001
Symbol/Image
Otsuka America Pharmaceutical, Inc.
2019-05-02
FRAMEWORKS
"FRAMEWORKS"
88397524
FRAMEWORKS
Otsuka America Pharmaceutical, Inc.
2019-04-23
Documents - otsuka-america-pharmaceutical,otsuka america pharmaceutical – otsuka america pharmaceutical,Otsuka America Pharmaceutical
[pdf] User Manual Instructions
IFU LayoutUpdate 15Dec22 02684 Wearable Sensor For Ambulatory Recording by Otsuka America Pharmaceutical Users Manual x7902684 ex 1 6 electric garden otsuka america pharmaceutical x79 manuals |||
Instructions for Use Otsuka Digital Feedback Device Customer support Phone: 1 844.692.4834 Otsuka America Pharmaceutical, Inc. 3956 Point Eden WayHayward, CA 94545 USA Rx Only LBL-0555, Rev 1, 15Dec2022 Introduction Your Otsuka Digital Feedback Device consists of a mobile application App , a patch ...
lang:en score:132 filesize: 1.9 M page_count: 1 document date: 2022-12-16
[pdf]
Otsuka America Pharmaceutical Inc 02684 X7902684
To: From: William Graff wgraff us.tuv.com Samuel Uganzenwoko Samuel.Uganzenwoko fcc.gov FCC Equipment Authorization Branch Re: FCC ID: X7902684 Applicant: Correspondence Number: 731 Confirmation Number: Date of Original E-Mail: Otsuka America Pharmaceutical, Inc. 552514 TC174727 04/08/2023 Subj...
lang:en score:119 filesize: 14.97 K page_count: 4 document date: 2023-04-08
[pdf] Confidentiality Request Letter
clevine@proteus Location Otsuka America Pharmaceutical Inc 02684 Wearable Sensor for Ambulatory Recording X7902684
SPC-2684 Rev 1 Draft 04Jan Patch, MyCite, Pouched, D-Tect Effective: ddmmmyyyy Patch, MyCite, Pouched, D-Tect SPC-2684 Otsuka America Pharmaceutical, Inc. TMP-0078 Rev 3 Effective: 22JUN2022 Confidential Page 1 of 10 SPC-2684 Rev 1 Draft 04Jan Patch, MyCite, Pouched, D-Tect Effective: ddmmmy...
lang:en score:114 filesize: 623.32 K page_count: 10 document date: 2023-02-22
[pdf] Confidentiality Request Letter
Microsoft Word LBL 0553 Rev 1 Label Pouch Patch D Tect veen39790 Otsuka America Pharmaceutical Inc 02684 Wearable Sensor for Ambulatory Recording X7902684
LBL-0553 Rev 1 Label, Pouch, Patch, D-Tect Effective: 06JAN2023 Label, Pouch, Patch, D-Tect LBL-0553 Otsuka America Pharmaceutical, Inc. TMP-0078 Rev 3 Effective: 22JUN2022 Confidential Page 1 of 5 LBL-0553 Rev 1 Label, Pouch, Patch, D-Tect Effective: 06JAN2023 1 Purpose/Description This do...
lang:en score:106 filesize: 228.49 K page_count: 5 document date: 2023-01-06
[pdf] Specifications Test Report
Alexander Sowinski Test report Otsuka America Pharmaceutical Inc 02684 Wearable Sensor for Ambulatory Recording X7902684
Test Report Products Prfbericht - Produkte Test Report No.: Prfbericht-Nr.: Client Reference No.: ... tragsdatum: 7/6/2022 Page 1 of 62 Seite 1 von 62 Client: Auftraggeber: Test item: Prfgegenstand: Otsuka America Pharmaceutical, Inc. 3956 Point Eden Way Hayward, CA 94545 USA Otsuka Patch Identifi...
lang:en score:98 filesize: 4.08 M page_count: 62 document date: 2022-11-22
[pdf]
Basic RGB For more information please visit OtsukaPatientSupport or call Otsuka America Pharmaceutical Inc Development Commercialization A note from our CEO to the patient communities we serve PatientLetter 10Apr2020 1688 otsuka us sites g files qhldwo6526 media images |||
A note from our CEO to the patient communities we serve. Over the past several weeks, we have been h ... ing of everyone. Sincerely Yours, KABIR NATH President CEO, North America Pharmaceutical Business Otsuka America Pharmaceutical, Inc. Otsuka America Pharmaceutical, Inc. Otsuka Pharmaceutical Develo...
lang:en score:98 filesize: 202.75 K page_count: 1 document date: 2020-04-10
[pdf] Specifications Test Report SAR Rating
Alexander Sowinski RFx Otsuka America Pharmaceutical Inc 02684 Wearable Sensor for Ambulatory Recording X7902684
Test Report Products Prfbericht - Produkte Test Report No.: Prfbericht-Nr.: Client Reference No.: ... uftragsdatum: 7/6/2022 Page 1 of 7 Seite 1 von 7 Client: Auftraggeber: Test item: Prfgegenstand: Otsuka America Pharmaceutical, Inc. 3956 Point Eden Way Hayward, CA 94545 USA Otsuka Patch Identifi...
lang:en score:91 filesize: 879.39 K page_count: 7 document date: 2022-11-22
[pdf]
August 11 2023 Otsuka America Pharmaceutical Inc Nancy août — We have reviewed your Section 510 k premarket notification of intent to market the device referenced above and determined is substantially K223463 accessdata fda gov cdrh docs 22 |||
August 11, 2023 Otsuka America Pharmaceutical, Inc. Nancy Teague Senior Director, Global Regulatory Affairs 2440 Research Boulevard Rockville, Maryland 20850 Re: K223463 Trade/Device Name: Otsuka Digital Feedback Device-RW Regulation Number: 21 CFR 880.6305 Regulation Name: Ingestible Event Marker ...
lang:en score:90 filesize: 2.69 M page_count: 7 document date: 2023-08-12
[pdf] Label
label SAMSCA tolvaptan tablets OTSUKA AMERICA PHARMACEUTICAL INC fda cder 022275s005lbl accessdata gov drugsatfda docs 2012 |||
HIGHLIGHTS OF PRESCRIBING INFORMATION These highlights do not include all the information needed to ... Manufactured by Otsuka Pharmaceutical Co., Ltd., Tokyo, 101-8535 Japan Distributed and marketed by Otsuka America Pharmaceutical, Inc., Rockville, MD 20850 SAMSCA is a registered trademark of Otsuka ...
lang:en score:77 filesize: 254.04 K page_count: 27 document date: 2012-02-02
[pdf] Label
label Samsca sildenafil 15 mg and 30 Tablets OTSUKA AMERICA PHARMACEUTICAL INC fda cder 022275s009lbl accessdata gov drugsatfda docs 2013 |||
HIGHLIGHTS OF PRESCRIBING INFORMATION These highlights do not include all the information needed to ... Manufactured by Otsuka Pharmaceutical Co., Ltd., Tokyo, 101-8535 Japan Distributed and marketed by Otsuka America Pharmaceutical, Inc., Rockville, MD 20850 Reference ID: 3289766 Page 22 of 27 SAM...
lang:en score:73 filesize: 505.98 K page_count: 27 document date: 2013-04-11
[pdf] Label
label Samsca tolvaptan 15 mg and 30 Tablets OTSUKA AMERICA PHARMACEUTICAL INC fda cder 022275s007lbl accessdata gov drugsatfda docs 2012 |||
HIGHLIGHTS OF PRESCRIBING INFORMATION These highlights do not include all the information needed to ... Manufactured by Otsuka Pharmaceutical Co., Ltd., Tokyo, 101-8535 Japan Distributed and marketed by Otsuka America Pharmaceutical, Inc., Rockville, MD 20850 Reference ID: 3217949 Page 22 of 27 SAM...
lang:en score:73 filesize: 506.83 K page_count: 27 document date: 2012-11-16
[pdf] Label
label Samsca tolvaptan 15 mg 30 and 60 Tablets OTSUKA AMERICA PHARMACEUTICAL INC fda cder 022275s014lbl accessdata gov drugsatfda docs 2014 |||
HIGHLIGHTS OF PRESCRIBING INFORMATION These highlights do not include all the information needed to ... Manufactured by Otsuka Pharmaceutical Co., Ltd., Tokyo, 101-8535 Japan Distributed and marketed by Otsuka America Pharmaceutical, Inc., Rockville, MD 20850 SAMSCA is a registered trademark of Otsuka ...
lang:en score:71 filesize: 464.78 K page_count: 28 document date: 2014-03-04
[pdf] Guide
Approval Rx ONLY Elizabeth Chen Jynarque 2019 12 03 Patient Guide accessdata fda gov drugsatfda docs rems |||
JYNARQUE REMS RISK EVALUATION AND MITIGATION STRATEGY PATIENT GUIDE Patients: Your healthcare prov ... OUR HEALTH OR MEDICINES, TALK TO YOUR HEALTHCARE PROVIDER. To report negative side effects, contact Otsuka America Pharmaceutical, Inc. at 1-800-438-9927 or FDA at 1-800-FDA-1088 www.fda.gov/medwatch...
lang:en score:67 filesize: 158.53 K page_count: 7 document date: 2019-12-04
[pdf] Guide
Approval Rx ONLY Elizabeth Chen Jynarque 2020 11 25 Patient Guide accessdata fda gov drugsatfda docs rems |||
JYNARQUE REMS RISK EVALUATION AND MITIGATION STRATEGY PATIENT GUIDE Patients: Your healthcare prov ... OUR HEALTH OR MEDICINES, TALK TO YOUR HEALTHCARE PROVIDER. To report negative side effects, contact Otsuka America Pharmaceutical, Inc. at 1-800-438-9927 or FDA at 1-800-FDA-1088 www.fda.gov/medwatch...
lang:en score:67 filesize: 161.85 K page_count: 7 document date: 2020-12-01
[pdf] Guide
Approval Rx ONLY US FDA Elizabeth Chen JYNARQUE 2023 09 29 Patient Guide accessdata fda gov drugsatfda docs rems |||
JYNARQUE REMS RISK EVALUATION AND MITIGATION STRATEGY PATIENT GUIDE Patients: Your healthcare prov ... OUR HEALTH OR MEDICINES, TALK TO YOUR HEALTHCARE PROVIDER. To report negative side effects, contact Otsuka America Pharmaceutical, Inc. at 1-800-438-9927 or FDA at 1-800-FDA-1088 www.fda.gov/medwatch...
lang:en score:67 filesize: 118.95 K page_count: 7 document date: 2023-10-03
[pdf] Instructions
PRESCRIPTION FORM FOR THE ABILIFY MYCITE® KIT April 2021 Please see FULL PRESCRIBING INFORMATION including compatible with the App For instructions on how your patient can if their a1afe9 8c9d55d4f013403eb2662fee4b2dab9d f hubspotusercontent30 net hubfs 7642930 OrsiniSpecialtyPharmacy September2020 Pdf 1
PRESCRIPTION FORM FOR THE ABILIFY MYCITE KIT Please fax completed form to: 844-9-MYCITE 844-969-248 ... re processing the refill Please see FULL PRESCRIBING INFORMATION, including BOXED WARNING. 2020 Otsuka America Pharmaceutical, Inc., Rockville, MD. 1 January 2020 12US20EBP0003 PRESCRIPTION F...
lang:en score:66 filesize: 401.1 K page_count: 2 document date: 2020-01-13
[pdf] Datasheet Safety Datasheet Accessories
Bandy Angela SDS FSHSCI TEST KIT H PYLORI OTSUKA BREATHTEK imgcdn mckesson CumulusWeb Click and learn |||
Safety Data Sheet Otsuka America Pharmaceutical, Inc. 2440 Research Blvd Rockville, MD 20850 Page 1 of 7 Emergency Contact Information: U.S Distributor Otsuka Medical Information 1-888-637-3835 SECTION 1: Product Identifier: IDENTIFICATION Lithium Hydroxide contained in CO2 Trapping Cartridge...
lang:en score:65 filesize: 481.84 K page_count: 14 document date: 2016-05-23
[pdf] Label
Redacted Label Drugs@FDA FDA Approved Drugs 205422Orig1s008lbl accessdata fda gov drugsatfda docs label 2022 |||
Day 1 0.5 mg Day 2 0.5 mg Day 3 0.5 mg Day 4 0.5 mg Day 5 0.5 mg REXULTI brexpiprazole NOT FOR SALE OR REIMBURSEMENT tablets Distributed and marketed by Rx only Otsuka America Pharmaceutical nc , Rockville, MD 20850 USA 1 mg Day 8 1 mg Day 9 1 mg Day 10 1 mg Day 11 1 mg Day 12 517357A...
lang:en score:64 filesize: 3.07 M page_count: 15 document date: 2022-10-07
[pdf] Instructions Guide
ABILIFY MYCITE MEDGUIDE Parihar Simran MEDICATION GUIDE MYCITE® a BIL ĭ fī Otsuka US 13 nov 2017 — Mi SIHYT aripiprazole tablets with sensor for oral use Important If you are taking MYCITE  otsuka us sites g files qhldwo6706 media static |||
MEDICATION GUIDE ABILIFY MYCITE a BIL f - Mi SIHYT aripiprazole tablets with sensor , for oral u ... ufactured by Otsuka Pharmaceutical Co., Ltd., Tokyo, 101-8535 Japan MYCITE Patches Manufactured for Otsuka America Pharmaceutical, Inc. 3956 Point Eden Way, Hayward, CA 94545 USA Distributed and marke...
lang:en score:60 filesize: 229.85 K page_count: 5 document date: 2022-12-07
[pdf] Decleration of Conformity
Annual Declaration of Compliance tsuka America Pharmaceutical Inc 2440 Research Boulevard Rockville Maryland 20850 Phone 301 990 0030 Fax 0035 otsuka us Otsuka 01US22EUC0110 2022 California sites g files qhldwo6181 media static |||
Annual Declaration of Compliance July 1, 2022 Otsuka America Pharmaceutical, Inc. has established a Comprehensive Compliance Program CCP in accordance with California Health and Safety Code Sections 119400 -119402, and to the best of its knowledge and based on its good faith understanding of the s...
lang:en score:59 filesize: 78.13 K page_count: 1 document date: 2022-06-22
[pdf] Decleration of Conformity
Annual Declaration of Compliance ITG HelpDesk OTSUKA Otsuka US America Pharmaceutical Inc 2440 Research Boulevard Rockville Maryland 20850 Phone 301 990 0030 Fax 0035 otsuka us 2020 sites g files qhldwo4671 media static |||
Annual Declaration of Compliance July 1, 2021 Otsuka America Pharmaceutical, Inc. has established a Comprehensive Compliance Program CCP in accordance with California Health and Safety Code Sections 119400 -119402, and to the best of its knowledge and based on its good faith understanding of the s...
lang:en score:59 filesize: 158.14 K page_count: 1 document date: 2021-06-29
[pdf] Decleration of Conformity
OAPI Annual Declaration of Compliance Corporate social responsibility Otsuka US 01US23EUC0152 California otsuka us media static |||
California Annual Declaration of Compliance July 1, 2023 Otsuka America Pharmaceutical, Inc. has established a Comprehensive Compliance Program CCP in accordance with California Health and Safety Code Sections 119400 -119402, and to the best of its knowledge and based on its good faith understandi...
lang:en score:59 filesize: 79.08 K page_count: 1 document date: 2023-06-12
[pdf]
Here s Your REXULTI® brexpiprazole Savings Card Report any changes in these symptoms immediately to the doctor REXULTI is not approved for treatment of people younger than 18 years age 11US20EBC0051 REX Downloadable For GRx assets ctfassets net decnlygd8vub 27fmRWN9aKwq3VH1rEu3xF 310537fb4344c88ead01f7ac72127677 |||
Here s Your REXULTI brexpiprazole Savings Card: Using the card is simple. No activation required. ... side effects. You are encouraged to report side effects of REXULTI brexpiprazole . Please contact Otsuka America Pharmaceutical, Inc. at 1-800-438-9927 or FDA at 1-800-FDA-1088 www.fda.gov/medwatch...
lang:en score:58 filesize: 2.03 M page_count: 3 document date: 2021-05-05
[pdf] Label
BreathTek® UBT for H pyloriKit Shelf Life and Storage Change 22 apr 2020 — Otsuka BreathTek pylori Kit Label Update imgcdn mckesson CumulusWeb Click learn
April 22, 2020 Information Update: BreathTek UBT for H. pylori Kit Shelf Life and Storage Change Dear BreathTek UBT Customer: The Medical Device Division of Otsuka America Pharmaceutical, Inc. MDD-OAPI is sending this letter to notify you of recent changes to the labeling for the BreathTek UBT Kit...
lang:en score:58 filesize: 6.17 M page_count: 2 document date: 2020-04-28
[pdf]
11US23EBC0104 REXULTI Consumer Downloadable Savings Card assets ctfassets net 4f3rgqwzdznj 38PadJqpUr19gB8E7c6qZ3 8295bbb43b6237c1fc33dce23487b9d8 |||
Here s Your REXULTI brexpiprazole Savings Card: Using the card is simple. No activation required. ... her injuries. You are encouraged to report side effects of REXULTI brexpiprazole . Please contact Otsuka America Pharmaceutical, Inc. at 1-800-438-9927 or FDA at 1-800-FDA-1088 www.fda.gov/medwatch...
lang:en score:58 filesize: 2.5 M page_count: 3 document date: 2023-06-12
[pdf] User Manual Instructions
Manual Otsuka America Pharmaceutical Inc 01913 Proteus Two part patch Model RW2 X7901913
Follow the instructions in your app to put your patch together, connect it with your mobile device, and place it on your body. Patch Pod Strip Your patch is made up of a pod and disposable strip. The pod can be used for weeks or months at a time. It captures and sends information to your mobile ap...
lang:en score:58 filesize: 176.37 K page_count: 1 document date: 2016-06-07
[pdf]
HIGHLIGHTS OF PRESCRIBING INFORMATION These highlights do not include all the information needed to use ARIPIPRAZOLE TABLETS safely and effectively See full prescribing for tablets oral Initial U S Approval 2002 20220709 bde2d571 7a0a 42c8 89e5 6bcaffa52008 dailymed nlm nih gov getFile cfm setid type |||
ARIPIPRAZOLE - aripiprazole tablet A-S Medication Solutions ---------- HIGHLIGHTS OF PRESCRIBING IN ... COUNSELING INFORMATION and Medication Guide. Additional pediatric use information is approved for Otsuka America Pharmaceutical, Inc. s ABILIFY aripiprazole product. However, due to Otsuka Americ...
lang:en score:58 filesize: 734.05 K page_count: 33 document date: 2022-07-11
[pdf]
HIGHLIGHTS OF PRESCRIBING INFORMATION These highlights do not include all the information needed to use ARIPIPRAZOLE TABLETS safely and effectively See full prescribing for tablets oral Initial U S Approval 2002 20211106 a176d300 230b 4dd5 9af4 d0b5af7c57ea dailymed nlm nih gov getFile cfm setid type |||
ARIPIPRAZOLE - aripiprazole tablet A-S Medication Solutions ---------- HIGHLIGHTS OF PRESCRIBING IN ... COUNSELING INFORMATION and Medication Guide. Additional pediatric use information is approved for Otsuka America Pharmaceutical, Inc. s ABILIFY aripiprazole product. However, due to Otsuka Americ...
lang:en score:58 filesize: 733.77 K page_count: 33 document date: 2021-11-08
[pdf]
 These highlights do not include all the information needed to use ARIPIPRAZOLE TABLETS safely and effectively See full prescribing for tablets oral Initial U S Approval 2002   20210416 8690e8a5 0bec 4aa2 8d70 62b54d8ea8c2 dailymed nlm nih gov getFile cfm setid type |||
ARIPIPRAZOLE - aripiprazole tablet A-S Medication Solutions ---------- HIGHLIGHTS OF PRESCRIBING IN ... n neonates with third trimester exposure 8.1 Additional pediatric use information is approved for Otsuka America Pharmaceutical, Inc. s ABILIFY aripiprazole product. However, due to Otsuka America...
lang:en score:57 filesize: 434.03 K page_count: 49 document date: 2021-04-16
[pdf]
Otsuka America Pharmaceutical Inc 02684 X7902684
To: Date: Subject: Samuel Uganzenwoko 4/10/2023 12:26:40 Attestation letters required Message: All three documents should now be available. ...
lang:en score:57 filesize: 6 K page_count: 1 document date: 2023-04-10
[pdf] Documentation
Otsuka America Pharmaceutical Inc 02684 X7902684
To: Date: Subject: Samuel Uganzenwoko 9/14/2023 11:25:57 Message: All Documentation provided and accepted. ...
lang:en score:57 filesize: 5.96 K page_count: 1 document date: 2023-09-14
[pdf]
Basic RGB Otsuka US 8 dic 2022 — Over the past several weeks we have been heartened by mobilization of countries worldwide who come together in a massive global public health  01US20EUP0026COVID 19CustomerLetter 1691 otsuka us sites g files qhldwo6321 media images |||
A note from our CEO to our customers, Over the past several weeks, we have been heartened by the mob ... immediate needs. Sincerely Yours, KABIR NATH President CEO, North America Pharmaceutical Business Otsuka America Pharmaceutical, Inc. Otsuka America Pharmaceutical, Inc. Otsuka Pharmaceutical Develo...
lang:en score:57 filesize: 206.36 K page_count: 1 document date: 2020-04-15
[pdf] User Manual Instructions
PRANACTIN CITRIC urea c 13 powder for DailyMed Refer to the Instruction Manual instrument C Method Comparisons in Clinical Trials 1 Comparison of BreathTek™ UBT with Meretek 20100108 571577b1 2160 4c2f b953 062c15373fcb dailymed nlm nih gov getFile cfm setid type
PRANACTIN-CITRIC - urea c-13 powder, for s olution Ots uka America Pharmaceutical ---------- Introdu ... s The BreathTekTM UBT for H. pylori Collection Kit is manufactured for Meretek Diagnostics Group of Otsuka America Pharmaceutical, Inc., 2440 Research Boulevard, Rockville, MD 20850. XV. Labeling Revi...
lang:en score:57 filesize: 186.56 K page_count: 13 document date: 2016-04-29
[pdf]
HIGHLIGHTS OF PRESCRIBING INFORMATION These highlights do not include all the information needed to use ARIPIPRAZOLE TABLETS safely and effectively See full prescribing for tablets oral Initial U S Approval 2002 20210618 2d8d574b fbf4 4d2c a37c 25556ecbf1aa dailymed nlm nih gov getFile cfm setid type |||
ARIPIPRAZOLE - aripiprazole tablet Camber Pharmaceuticals, Inc. ---------- HIGHLIGHTS OF PRESCRIBIN ... COUNSELING INFORMATION and Medication Guide. Additional pediatric use information is approved for Otsuka America Pharmaceutical, Inc. s ABILIFY aripiprazole product. However, due to Otsuka Americ...
lang:en score:57 filesize: 1.39 M page_count: 38 document date: 2021-06-18
[pdf]
These highlights do not include all the information needed to use ARIPIPRAZOLE TABLETS safely and effectively See full prescribing for tablets oral Initial U S Approval 2002 20211113 569f1c32 fb6f c34f 0894 4b1e7b744a8a dailymed nlm nih gov getFile cfm setid type |||
ARIPIPRAZOLE- aripiprazole tablet Apotex Corp ---------- HIGHLIGHTS OF PRESCRIBING INFORMATION Thes ... n neonates with third trimester exposure 8.1 Additional pediatric use information is approved for Otsuka America Pharmaceutical, Inc. s ABILIFY aripiprazole product. However, due to Otsuka America...
lang:en score:57 filesize: 910.77 K page_count: 35 document date: 2021-11-16
[pdf]
These highlights do not include all the information needed to use ARIPIPRAZOLE TABLETS safely and effectively See full prescribing for tablets oral Initial U S Approval 2002 20210417 df703fad 84f9 4ceb bbd5 4e4bb8ae180d dailymed nlm nih gov getFile cfm setid type |||
ARIPIPRAZOLE- aripiprazole tablet A-S Medication Solutions ---------- HIGHLIGHTS OF PRESCRIBING INFO ... n neonates with third trimester exposure 8.1 Additional pediatric use information is approved for Otsuka America Pharmaceutical, Inc. s ABILIFY aripiprazole product. However, due to Otsuka Americ...
lang:en score:57 filesize: 577.63 K page_count: 48 document date: 2021-04-19
[pdf]
These highlights do not include all the information needed to use ARIPIPRAZOLE TABLETS safely and effectively See full prescribing for tablets oral Initial U S Approval 2002 20210416 dca04230 168f 462a babe 4bea20a9422a dailymed nlm nih gov getFile cfm setid type |||
ARIPIPRAZOLE- aripiprazole tablet A-S Medication Solutions ---------- HIGHLIGHTS OF PRESCRIBING INFO ... n neonates with third trimester exposure 8.1 Additional pediatric use information is approved for Otsuka America Pharmaceutical, Inc. s ABILIFY aripiprazole product. However, due to Otsuka Americ...
lang:en score:57 filesize: 577.56 K page_count: 48 document date: 2021-04-16
[pdf]
These highlights do not include all the information needed to use ARIPIPRAZOLE TABLETS safely and effectively See full prescribing for tablets oral Initial U S Approval 2002 20210814 aa6ad389 08ab 577f e053 2a95a90a02ec dailymed nlm nih gov getFile cfm setid type |||
ARIPIPRAZOLE- aripiprazole tablet Denton Pharma, Inc. dba Northwind Pharmaceuticals ---------- HIGHL ... n neonates with third trimester exposure 8.1 Additional pediatric use information is approved for Otsuka America Pharmaceutical, Inc. s ABILIFY aripiprazole product. However, due to Otsuka Americ...
lang:en score:57 filesize: 599.11 K page_count: 48 document date: 2021-08-16
[pdf]
Approval Rx ONLY Elizabeth Chen Jynarque 2019 12 03 Letter for Healthcare Providers accessdata fda gov drugsatfda docs rems |||
IMPORTANT DRUG WARNING Month/Day/Year JYNARQUE REMS Letter for Healthcare Providers Subject: R isk ... ion through certified pharmacies. Adverse Events Reporting To report negative side effects, contact Otsuka America Pharmaceutical, Inc. at 1-800-438-9927 or FDA at 1-800-FDA-1088 www.fda.gov/medwatch...
lang:en score:56 filesize: 81.48 K page_count: 2 document date: 2019-12-04
[pdf]
Approval Rx ONLY Elizabeth Chen Jynarque 2020 11 25 Letter for Healthcare Providers accessdata fda gov drugsatfda docs rems |||
IMPORTANT DRUG WARNING Month/Day/Year JYNARQUE REMS Letter for Healthcare Providers Subject: R isk ... ion through certified pharmacies. Adverse Events Reporting To report negative side effects, contact Otsuka America Pharmaceutical, Inc. at 1-800-438-9927 or FDA at 1-800-FDA-1088 www.fda.gov/medwatch...
lang:en score:56 filesize: 83.58 K page_count: 2 document date: 2020-12-01
[pdf] Label
label ARIPIPRAZOLE alembic pharmaceuticals fda cder Label Drugs@FDA FDA Approved Drugs 202102s000lbl accessdata gov drugsatfda docs 2015 |||
This label may not be the latest approved by FDA. For current labeling information, please visit htt ... polar I Disorder see CLINICAL STUDIES 14.2 Additional pediatric use information is approved for Otsuka America Pharmaceutical, Inc. s ABILIFY aripiprazole product. However, due to Otsuka America...
lang:en score:56 filesize: 1.73 M page_count: 4 document date: 2024-06-17
[pdf] Label
Aripiprazole Tablets POS 20014081 Trigen 19 04 15 Administrator Label Drugs@FDA FDA Approved Drugs 202101s000lbl accessdata fda gov drugsatfda docs label 2015 |||
This label may not be the latest approved by FDA. For current labeling information, please visit htt ... polar I Disorder see CLINICAL STUDIES 14.2 Additional pediatric use information is approved for Otsuka America Pharmaceutical, Inc. s ABILIFY aripiprazole product. However, due to Otsuka America...
lang:en score:56 filesize: 1.73 M page_count: 4 document date: 2015-04-18
[pdf]
These highlights do not include all the information needed to use ARIPIPRAZOLE ORALLY DISINTEGRATING TABLETS safely and effectively See full prescribing for orally disintegrating tablets Initial U S Approval 2002 20210722 394ea4a4 3991 4f98 b38f 56e9335d66b3 dailymed nlm nih gov getFile cfm setid type |||
ARIPIPRAZOLE- aripiprazole orally disintegrating tablet Dr. Reddy s Laboratories Inc ---------- HIG ... neonates with third trimester exposure 8.1 Additional pediatric use information is approved for Otsuka America Pharmaceutical, Inc. s ABILIFY aripiprazole product. However, due to Otsuka Americ...
lang:en score:56 filesize: 1.07 M page_count: 49 document date: 2021-07-22
[pdf]
These highlights do not include all the information needed to use ARIPIPRAZOLE ORALLY DISINTEGRATING TABLETS safely and effectively See full prescribing for orally disintegrating tablets Initial U S Approval 2002 20210709 4bcfd5a7 bec7 4426 9314 17daaf715cad dailymed nlm nih gov getFile cfm setid type |||
ARIPIPRAZOLE- aripiprazole orally disintegrating tablet ScieGen Pharmaceuticals Inc ---------- HIGH ... neonates with third trimester exposure 8.1 Additional pediatric use information is approved for Otsuka America Pharmaceutical, Inc. s ABILIFY aripiprazole product. However, due to Otsuka Americ...
lang:en score:56 filesize: 1.45 M page_count: 52 document date: 2021-07-09
[pdf]
These highlights do not include all the information needed to use ARIPIPRAZOLE TABLETS safely and effectively See full prescribing for tablets oral Initial U S Approval 2002 20210615 554db933 aa80 4685 bcd5 58c84571c19c dailymed nlm nih gov getFile cfm setid type |||
ARIPIPRAZOLE - aripiprazole tablet A-S Medication Solutions ---------- HIGHLIGHTS OF PRESCRIBING IN ... n neonates with third trimester exposure 8.1 Additional pediatric use information is approved for Otsuka America Pharmaceutical, Inc. s ABILIFY aripiprazole product. However, due to Otsuka America...
lang:en score:56 filesize: 588.91 K page_count: 45 document date: 2021-06-15
[pdf]
These highlights do not include all the information needed to use ARIPIPRAZOLE TABLETS safely and effectively See full prescribing for tablets oral Initial U S Approval 2002 20210615 3ab6af7c 3169 46bf bd3f 697c81bbcede dailymed nlm nih gov getFile cfm setid type |||
ARIPIPRAZOLE - aripiprazole tablet A-S Medication Solutions ---------- HIGHLIGHTS OF PRESCRIBING IN ... n neonates with third trimester exposure 8.1 Additional pediatric use information is approved for Otsuka America Pharmaceutical, Inc. s ABILIFY aripiprazole product. However, due to Otsuka America...
lang:en score:56 filesize: 589.22 K page_count: 45 document date: 2021-06-15
[pdf]
These highlights do not include all the information needed to use ARIPIPRAZOLE TABLETS safely and effectively See full prescribing for tablets oral Initial U S Approval 2002 20210615 bf3cf835 4c4e 47cb be9c bcb7c2e11cbe dailymed nlm nih gov getFile cfm setid type |||
ARIPIPRAZOLE - aripiprazole tablet A-S Medication Solutions ---------- HIGHLIGHTS OF PRESCRIBING IN ... n neonates with third trimester exposure 8.1 Additional pediatric use information is approved for Otsuka America Pharmaceutical, Inc. s ABILIFY aripiprazole product. However, due to Otsuka America...
lang:en score:56 filesize: 588.99 K page_count: 45 document date: 2021-06-15
[pdf]
These highlights do not include all the information needed to use ARIPIPRAZOLE TABLETS safely and effectively See full prescribing for tablets oral Initial U S Approval 2002 Aripiprazole by NCS HealthCare of KY LLC dba Vangard Labs tablet 8DA99C93 613E 4B78 9F91 3EFC2DEA194D fda report DailyMed |||
ARIPIPRAZOLE- aripiprazole tablet NCS HealthCare of KY, LLC dba Vangard Labs ---------- HIGHLIGHTS O ... neonates with third trimester exposure 8.1 Additional pediatric use information is approved for Otsuka America Pharmaceutical, Inc. s ABILIFY aripiprazole product. However, due to Otsuka Americ...
lang:en score:56 filesize: 915.81 K page_count: 46 document date: 2022-08-04
[pdf]
These highlights do not include all the information needed to use ARIPIPRAZOLE TABLETS safely and effectively See full prescribing for tablets oral Initial U S Approval 2002 Aripiprazole by REMEDYREPACK INC tablet 6F580E75 61AB 4C7B BB3F F027A9603F84 fda report DailyMed |||
ARIPIPRAZOLE- aripiprazole tablet REMEDYREPACK INC. ---------- HIGHLIGHTS OF PRESCRIBING INFORMATIO ... neonates with third trimester exposure 8.1 Additional pediatric use information is approved for Otsuka America Pharmaceutical, Inc. s ABILIFY aripiprazole product. However, due to Otsuka Americ...
lang:en score:56 filesize: 641.69 K page_count: 46 document date: 2022-11-18
[pdf]
These highlights do not include all the information needed to use ARIPIPRAZOLE TABLETS safely and effectively See full prescribing for ARIPIPRAZOLE  tablets oral Initial U S Approval 2002 20211003 a10a5427 58b1 42dd 964c 3f8c78770534 dailymed nlm nih gov getFile cfm setid type |||
ARIPIPRAZOLE - aripiprazole tablet Alembic Pharmaceuticals Inc. ---------- HIGHLIGHTS OF PRESCRIBIN ... n neonates with third trimester exposure 8.1 Additional pediatric use information is approved for Otsuka America Pharmaceutical, Inc. s ABILIFY aripiprazole product. However, due to Otsuka America...
lang:en score:56 filesize: 868.73 K page_count: 57 document date: 2021-10-04

Related FCC IDs:


Search Any Device: